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Autophagy (literally self-eating) has diverse cytoprotective functions but also is linked 
to programmed cell death (PCD). In this issue, Qu et al. (2007) analyze the role of 
autophagy in PCD during development. Unexpectedly they find that autophagy induces 
apoptotic cells to present a signal to ensure their clearance, which is crucial for mouse 
embryonic morphogenesis.Macroautophagy (herein referred to as autophagy) is 
a unique form of membrane trafficking in which mem-
brane compartments (autophagosomes) engulf both 
organelles and cytosolic macromolecules and deliver 
them to the lysosome/vacuole for degradation (reviewed 
in Mizushima, 2005). Although electron microscopists 
first recognized the process in animal tissues in the early 
1960s, it took 30 years to decipher the molecular com-
ponents of this curious phenomenon. Groundbreaking 
studies in yeast have identified over 20 autophagy-related 
(ATG) genes and have shed light on the molecular com-
ponents of autophagy (reviewed in Yorimitsu and Klion-
sky, 2005). In yeast, the primary function of autophagy 
is to maintain viability during times of starvation. Many 
of the ATG genes are conserved in metazoans includ-
ing mammals, and extensive studies during the last ten 
years have unexpectedly revealed a pleiotropic role for 
autophagy in the protection and maintenance of cellu-
lar life as well as in response to starvation (Mizushima, 
2005). On the other hand, a large body of evidence indi-
cates a link between autophagy and programmed cell 
death (PCD) (reviewed in Levine and Yuan, 2005). This 
Minireview will briefly summarize our current knowledge 
about the role of autophagy in animals in cellular life 
and death and will introduce a new function: to provide 
apoptotic cells with a signal to ensure their clearance 
in morphogenesis during development (Qu et al., 2007). 
This function is reminiscent of a story in Greek mythol-
ogy where a coin is placed in the mouth or hand of the 
dead to pay Charon for ferrying the spirit across the river 
Styx to the Elysian Fields.
Autophagy, a Cellular Guardian
In mammals, severe starvation at birth, due to loss of the 
placental nutrient supply, induces autophagy in various 
neonatal tissues, such as heart, lung, and pancreas. In 
the absence of Atg5, which is required for autophago-
some formation, mice do not survive neonatal starva-
tion and die within a day after birth, suggesting that 
autophagy is essential to overcome starvation (Kuma et 
al., 2004). In vitro, starvation usually induces apoptosis in normal mammalian cells. However, cells that respond 
to IL3—an interleukin that directs the uptake of extra-
cellular nutrients into cells—and lack the apoptotic pro-
teins Bax and Bak can survive even for several weeks in 
the absence of IL3. Autophagy is indispensable for this 
long period of survival because small interfering (si)RNA 
against ATG7 decreased the viability of these cells (Lum 
et al., 2005). How does autophagy antagonize nutrient 
starvation? Perhaps, the products of self-degradation 
in lysosomes, such as amino acids, support the tricar-
boxylic acid (TCA) cycle to generate ATP necessary for 
maintaining cell viability.
Animal cells exhibit low levels of constitutive 
autophagy even under normal dietary conditions. What 
is the role of this basal autophagy? Two independent 
studies using conditional knockout mice whose brains 
lacked Atg5 and Atg7, respectively, demonstrated that 
absence of this basal autophagy in brain tissue caused 
neurodegenerative disease (Hara et al., 2006; Kom-
atsu et al., 2006). Although these mice are not geneti-
cally prone to the disease, cytoplasmic inclusion bodies 
accumulated in their neurons. Thus, basal autophagy 
is probably critical for clearance of spontaneously and 
constitutively generated misfolded proteins. Further-
more, accumulating evidence strongly suggests that 
both autophagy and the proteasome defend neurons 
against aggregate-prone toxic mutant proteins (such as 
expanded polyglutamine-containing proteins) that cause 
neurodegenerative disease. In this case, autophagy 
seems to selectively degrade abnormal proteins in con-
trast to basal and starvation-induced autophagy, which 
is thought to be nonselective. This function is not lim-
ited to nerve cells—the α1-antitrypsin Z mutant protein, 
which accumulates in the endoplasmic reticulum (ER) 
of liver cells and causes liver degeneration, is targeted 
by autophagosomes. In Atg5-deficient cells, this mutant 
protein was not degraded efficiently and accumulated 
in large inclusion bodies that were observed at a lower 
frequency in wild-type cells (Kamimoto et al., 2006).
The function of autophagy in animals extends beyond 
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autophagic machinery is applied to cellular defense 
against invasive pathogens, which are, of course, not 
intrinsic components of cells. For example, group A 
Streptococcus enters host cells via the endocytic path-
way and escapes from endosomes into the cytoplasm 
to avoid lysosomal degradation. However, appearance 
of the bacteria in the cytoplasm triggers specialized 
autophagy, which selectively sequesters and kills the 
bacteria (Nakagawa et al., 2004). Some pathogens have 
acquired the ability to circumvent or hijack autophagy 
to survive within cells. Autophagy against unwelcome 
guests such as pathogens is another example of selec-
tive autophagy. Therefore, autophagy may have evolved 
in higher eukaryotes as an active defense system. In 
addition to innate immunity, autophagy also partici-
pates in adaptive immunity. Some cytosolic antigens 
are sequestered and degraded by autophagy and then 
processed for presentation on MHC class II molecules 
(reviewed in Mizushima, 2005). Also, autophagic elimi-
nation of superfluous organelles including peroxisomes, 
mitochondoria, and the ER maintains cellular homeosta-
sis. Developmental and anti-aging functions have been 
also suggested for autophagy (Mizushima, 2005).
Autophagy as Pluto
Autophagy is a remarkable feature of certain forms of 
nonapoptotic PCD termed autophagic cell death or 
type II cell death (Levine and Yuan, 2005). The term 
autophagic cell death may have misled people into think-
ing that autophagy triggers PCD. The term merely rep-
resents the fact that a large number of autophagosomes 
are observed in dying cells. Is autophagy responsible for 
cell death or is it induced to resist ongoing death? Or is 
autophagy merely a scavenger that clears cellular con-
tent prior to death to relieve phagocytes?
Pharmacological approaches in several in vitro sys-
tems have advocated that autophagy executes PCD. 
However, 3-methyladenine (3-MA), the autophagy inhib-
itor used in these experiments, inhibits not only class III 
PI3-kinase—which is essential in autophagosome forma-
tion—but also other classes of PI3-kinases and has side 
effects at the higher concentrations used for autophagy 
inhibition (Levine and Yuan, 2005). Given that a specific 
inhibitor of autophagy does not exist, genetic strate-
gies such as loss of functions are the best approach to 
analyze the involvement of autophagy in PCD. The first 
experiment demonstrating the involvement of autophagy 
in cell death was performed in mouse L929 fibroblas-
tic cells treated with zVAD, a caspase 8 inhibitor, which 
induces nonapoptotic death in this cell line (Yu et al., 
2004). RNAi-mediated knockdown of Atg7 or Beclin-1—
a mammalian homolog of Vps30/Atg6 that is a compo-
nent of class III PI3-kinase—reduced cell death induced 
by zVAD in these cells. Treatment with zVAD also caused 
selective autophagic degradation of catalase, which 
resulted in the accumulation of reactive oxygen species 
leading to cell death (Yu et al., 2006). A remaining ques-
tion is how catalase is recognized and why autophagy 834 Cell 128, March 9, 2007 ©2007 Elsevier Inc.does not target this enzyme under normal conditions. 
Furthermore, cell death induced by chemicals such 
as etoposide occurred via autophagy in cells deficient 
for apoptotic proteins Bax and Bak. This death did not 
occur when Atg5 and Beclin-1 were silenced (Shimizu 
et al., 2004). It was reported recently that autophagy 
acts upstream of apoptosis in death signaling induced 
by HIV envelope glycoproteins in uninfected bystander 
CD4 T lymphocytes because RNAi of Beclin-1 and Atg7 
inhibited the apoptotic process (Espert et al., 2006). The 
results suggest that autophagy can trigger cell death 
under specific conditions.
Meanwhile, there is evidence suggesting that Atg5 
is a bifunctional molecule involved in both autophagy 
and PCD. Atg5 was shown to play a crucial role in IFN-
γ-induced cell death in HeLa cells through interaction 
with Fas-associated protein with death domain (FADD). 
However, RNAi of FADD inhibited the Atg5-mediated cell 
death but did not inhibit formation of autophagosomes 
(Pyo et al., 2005). Thus, not autophagy itself but Atg5 
plays a role in the signaling. It was also demonstrated 
that various apoptotic stimuli caused calpain-medi-
ated cleavage of Atg5. This truncated product bound 
to antiapoptotic protein BcL-xL in mitochondoria and 
triggered apoptosis (Yousefi et al., 2006). Again, Atg5 
functioned as a pro-death factor independent of its role 
in autophagy.
Excessive nonselective autophagy may cause cell 
death by degrading cellular components essential for 
cell viability or by degrading inhibitors of PCD, such as 
antiapoptotic factors. Indeed, two studies support this 
possibility. Beclin-1 was originally identified as a protein 
binding to antiapoptotic Bcl-2 protein, and Bcl-2 nega-
tively regulates autophagy by binding to Beclin-1 (Pat-
tingre et al., 2005). Intriguingly, expression of Beclin-1 
mutants that cannot bind to Bcl-2 induced a higher level 
of autophagy than the level observed under starvation 
even under nutrient-rich conditions (Pattingre et al., 
2005). This mutant also simultaneously promoted cell 
death. A high level of autophagy also could be achieved 
in fly tissues by overexpression of Atg1, a Ser-Thr kinase 
that regulates autophagy, and this led to apoptotic cell 
death (Scott et al., 2007). In both cases, cell death was 
blocked by Atg5 RNAi or in an Atg8a mutant background, 
respectively, which means that these forms of cell death 
were probably due to higher levels of autophagy itself, 
and not simply to Beclin-1 or Atg1.
Taken together, it is clear that autophagy can trigger 
cell death in certain contexts including inhibition of apop-
tosis, viral protein expression, and the presence of high 
levels of autophagy. In addition, Atg5 may link autophagy 
to PCD. The situation in vivo is still unclear. Autophagy 
might contribute to immunodeficiency in an HIV-infected 
animal. In normal animals, does cell death induced by 
autophagy have any physiological significance? When 
autophagy functions as a cytoprotective mechanism, 
how do cells control its levels? Currently the connection 
between cell death and autophagy remains cryptic.
Figure 1. The Many Functions of Autophagy
Autophagy has many protective roles but may also be involved in programmed cell death. Qu et al. (2007) now show that autophagy, through the 
production of ATP, is important for presenting a signal (phosphatidylserine) on an apoptotic cell to ensure its clearance. This appears to be important 
in morphogenesis during early mouse embryonic development.Autophagy Pays Charon’s Toll
Autophagy is prominent in PCD during developmental 
processes such as lumen formation in some organs. 
However, as discussed above, if autophagy contributes 
to this PCD, it could do so in a variety of ways. To under-
stand the role of autophagy in PCD associated with 
morphogenesis, Qu et al. (2007) used an in vitro system 
that mimics the formation of the proamniotic cavity in 
the early mouse embryo. Embryonic cavitation can be 
recapitulated in vitro in embryoid bodies (EBs) formed 
by culturing mouse embryonic stem (ES) cells in the 
absence of feeder cells and leukemia-inhibitory factor. 
EBs are cell aggregates consisting of an outer endoder-
mal cell layer and an inner ectodermal cell core. During 
cavitation, inner cells die by apoptosis, and neighbor-
ing cells remove the dead cells by phagocytosis to form 
a cavity. Inner ectodermal cells in EBs from knockout 
mice lacking Beclin-1 or Atg5 underwent apoptosis nor-
mally but could not be eliminated because they were not 
engulfed by neighboring cells. It is known that phagocy-
tosis of apoptotic cells depends on signals from these 
cells including exposure of phosphatidylserine on the 
cell surface and secretion of lysophosphatidylcholine. 
Beclin-1- or Atg5-deficient inner ectodermal cells in 
EBs failed to produce these signals efficiently. Thus, 
autophagy is dispensable for apoptosis during embry-
onic cavitation but essential for presentation of the sig-
nal by apoptotic cells, which is crucial for their clearance 
to form the embryonic cavity.
Qu et al. further demonstrated that ATP levels were 
significantly lower in ES cells lacking autophagic abil-
ity. Addition of methylpyruvate—a cell-permeable form 
of pyruvate serving as a substrate for the TCA cycle— 
rescued the defect in generating the signal and thus 
restored the clearance of apoptotic cells. Together with 
the observation that autophagy is induced in inner ecto-
dermal cells during EB development, they concluded 
that autophagy induced in cells undergoing apoptosis 
produced ATP to generate the signal for being engulfed. 
Finally, they showed an increase in the number of apop-totic cells and a decrease in the number of engulfed cells 
in the retina and lung of Atg5 knockout mice embryos, 
suggesting that autophagy helps clear apoptotic cells in 
vivo as well.
A new item is now added to the growing list of the 
functions of autophagy, which is neither cytoprotective 
nor pro-cell death but contributes to development (Fig-
ure 1). This exciting finding brings up a number of issues. 
Why is autophagy required for ATP generation in EBs 
despite cavitation in nutrient-rich conditions? Perhaps 
this is due to the lack of signal transduction pathways 
essential for nutrient uptake in the inner cells. Interest-
ingly, autophagy was not required for phosphatidyl-
serine exposure in single ES cell cultures treated with 
apoptosis inducers such as etoposide (Qu et al., 2007). 
Thus, the regulation of phosphatidylserine exposure in 
ES cells changes in the three-dimensional architecture 
of cells and/or during development. The ATP-dependent 
mechanism for phosphatidylserine exposure in EBs is an 
enigma. In the final stage of erythropoiesis, nuclei are 
expelled from erythroid precursor cells and engulfed by 
macrophages. The released nuclei expose phosphati-
dylserine to be engulfed (Yoshida et al., 2005). Phos-
phatidylserine is normally confined to the inner leaflet of 
the plasma membrane by action of an ATP-dependent 
aminophospholipid translocase that translocates phos-
phatidylserine from the outer leaflet to the inner leaflet. 
As the expelled nuclei contains an undetectable level of 
ATP and a higher level of Ca2+, it has been hypothesized 
that the aminophospholipid translocase becomes inac-
tive, while the activated Ca2+-dependent scramblase ran-
domizes lipids across the bilayer. This causes a shift in 
the lipid composition of the membrane with more phos-
phatidylserine in the outer leaflet (Yoshida et al., 2005). 
Thus, in contrast with Qu et al., lower levels of ATP cor-
respond with phosphatidylserine exposure. Future work 
should reconcile these discrepancies and clarify the 
mechanisms of autophagy-dependent surface exposure 
of phosphatidylserine in EBs. Discrepancy also exists 
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Atg5 knockout mouse. The former, but not the latter, fails 
to form proamniotic cavities, consistent with the results 
obtained in vitro. Beclin-1 knockout mice are embryonic 
lethal, whereas Atg5 knockout mice are born without vis-
ible abnormality (Kuma et al., 2004). One possible expla-
nation is that unknown factors compensate in embryos 
for the lack of Atg5 but not for the lack of beclin-1. 
However, Atg5 knockout mouse neonates show severe 
defects in autophagy. Alternatively, Beclin-1 may have 
an additional function other than autophagy. In fact, its 
yeast homolog Vps30/Atg6 functions in both autophagy 
and membrane trafficking to the vacuole (Yorimitsu and 
Klionsky, 2005).
Although Atg5 knockout mice did not exhibit severe 
developmental defects, the clearance of apoptotic cells 
seemed to be impaired and an increase in the number 
of inflammatory cells including lymphocytes in the tis-
sues was observed (Qu et al., 2007). Thus, insufficient 
removal of apoptotic cells causes unwanted inflamma-
tory responses indicating that this clearance function is 
crucial not only for development but also tissue homeos-
tasis in adult animals. Interestingly, a variant of Atg16L1, 
an Atg5-binding protein, is associated with Crohn’s dis-
ease (Hampe et al., 2007). Crohn’s disease is a chronic 
inflammatory disease of the intestine, the cause of 
which is unknown. Given that physiological regenera-
tion of colonic epithelium is accompanied by cell loss 
due to shedding or apoptosis, the effective clearance of 
apoptotic cells, which may involve autophagy, might be 
important to prevent inflammation.
Future Directions
In the dreamlike novel Hard-Boiled Wonderland and the 
End of the World, the author, Haruki Murakami, describes 
a man whose consciousness exists in two distinct paral-
lel worlds. Murakami asks readers what consciousness 
is and what reality is. Like the protagonist in this book, 
scientists working on autophagy seem to be wandering 
between two worlds: in one autophagy kills cells and 
in the other it sustains cells. Qu et al. now add a new 
dimension to this paradox by reporting that autophagy is 
required for apoptotic cells to express the correct signal 
so that they are cleared appropriately.
Although our knowledge of autophagy is growing day 
by day, we need more insights into the regulation and 
molecular machinery of autophagy to further under-
stand its importance in diverse cellular processes. 
Although over 20 Atg proteins have been identified, how 
they function and are regulated is still largely unknown. 
Formation of autophagosomes stands apart from vesi-
cle formation in other membrane traffic. In endocytic 
and secretory pathways, transport vesicles are formed 
by budding from the large flat membrane of donor 
organelles. In contrast, autophagosomes are formed 
de novo in the cytoplasm so that it requires unique 
mechanisms other than those used in the canonical 836 Cell 128, March 9, 2007 ©2007 Elsevier Inc.membrane traffic. No one knows how autophagosome 
formation initiates and how the membrane elongates 
and makes a curve autonomously. We need to further 
explore the heart of the autophagic wonderland.
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